Ligand Pharmaceuticals Inc.

12/13/2022 | Press release | Archived content

Investor and Analyst Day

Ligand Pharmaceuticals Inc. published this content on December 13, 2022, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 29, 2025 at 13:26 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]